Alternative treatment of psoriasis - is rifampicin a mild immunosupressor? / Alternativna terapija psorijaze: da li rifampicin ima blago imunosupresivno dejstvo?
By: Ivan Grozev, Jana Kazandjeva and Nikolai Tsankov
Open Access
|Feb 2013Abstract
Psoriasis is a common T-cell-mediated autoimmune inflammatory disease. Conventional systemic therapy includes: methotrexate, cyclosporine, retinoids and psoralen ultraviolet A, which are effective, but associated with toxicity and adverse effects which may limit their long-term use. Although effective as well, data on the long-term safety of newly introduced biologic agents are still not available. Herein, we present our clinical experience with rifampicin in the treatment of psoriasis, and review of literature regarding its potential mechanisms of action.
DOI: https://doi.org/10.2478/v10249-011-0017-9 | Journal eISSN: 2406-0631
Language: English
Page range: 5 - 12
Published on: Feb 12, 2013
Published by: Serbian Association of Dermatovenereologists (SAD)
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2013 Ivan Grozev, Jana Kazandjeva, Nikolai Tsankov, published by Serbian Association of Dermatovenereologists (SAD)
This work is licensed under the Creative Commons License.